ストックスクリーナーアプリを入手
0.5883
5.89%
0.0327
プレマーケット:
.59
0.0017
+0.29%
前日終値:
$0.5556
開ける：
$0.5555
24時間の取引高:
4.54M
Relative Volume:
0.61
時価総額：
$6.31M
収益：
$5.75M
当期純損益:
$-38.96M
株価収益率:
-0.0472
EPS:
-12.47
ネットキャッシュフロー:
$-32.63M
1週間 パフォーマンス:
-23.59%
1か月 パフォーマンス:
-15.84%
6か月 パフォーマンス:
-85.93%
1年 パフォーマンス:
-90.50%
1日の値動き範囲:
$0.5506
$0.67
1週間の範囲:
$0.55
$0.80
52週間の値動き範囲:
$0.55
$20.60
Kala Bio Inc Stock (KALA) Company Profile
KALA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.5883 | 5.96M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-09-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | 開始されました | Mizuho | Outperform |
| 2025-07-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
Kala Bio dismisses Deloitte as auditor, no successor named By Investing.com - Investing.com Nigeria
Kala Bio dismisses Deloitte as auditor, no successor named - Investing.com India
Top Penny Stocks To ResearchDecember 4th - MarketBeat
Kala Bio sets annual meeting for January 30, 2026 and updates on investment agreements By Investing.com - Investing.com Nigeria
KALA BIO Announces New CEO and Funding Deal - TipRanks
KALA BIO (Nasdaq: KALA) details Lazar financing shift and 2026 meeting - Stock Titan
Can Sobha Limited Maintain Its Share of Global Market for Its ProductUtilities Sector Analysis & Affordable Portfolio Trading - earlytimes.in
What drives KALA BIO Inc stock priceSmall Cap Stock Opportunities & Low Risk Wealth Plans - earlytimes.in
You might want to take a look at Kala Bio Inc (KALA) now - setenews.com
Kala Bio enters securities purchase agreement with David Lazar, names him CEO - MSN
Kala Bio Shares Jump After $6 Million Funding Deal With Investor David Lazar - MSN
KALA BIO Raises $10M in Direct Offering - TipRanks
KALA BIO closes $10 million registered direct offering - Investing.com India
KALA BIO Raises $10 Million From Direct Offering - marketscreener.com
KALA BIO closes $10 million registered direct offering By Investing.com - Investing.com South Africa
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO (NASDAQ: KALA) completes $10 million offering of 10,000,000 shares to repay debt - Stock Titan
Will KALA BIO Inc. stock continue upward momentumMarket Risk Summary & Community Consensus Picks - Newser
Kala Bio raises $10 million in registered direct offering By Investing.com - Investing.com Nigeria
KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update - ts2.tech
KALA BIO, Inc. (KALA) Stock: Surges 21.62% Amid Exciting New Offering Announcement - parameter.io
KALA Bio (KALA) Announces $10 Million Direct Stock Offering - GuruFocus
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors - ts2.tech
Kala Bio announces $10 mln registered direct offering of common stock - marketscreener.com
Kala Bio Reports $10 Million Direct Stock Offering; Shares Rise - marketscreener.com
Kala Bio raises $10 million in registered direct offering - Investing.com
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO Announces $10 Million Registered Direct Offering - GlobeNewswire
KALA Bio’s Bold Move: A New Dawn? - timothysykes.com
Aug Mood: Will KALA BIO Inc stock continue upward momentumTrade Analysis Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Will KALA BIO Inc. stock split attract more investors2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
KALA BIO, Inc. (KALA) -10.9% in Intraday Trading: Shares Decline Amid Routine Activity - Stocks Telegraph
Top Small Cap Stocks To Follow Today – December 1st - Defense World
Is KALA BIO Inc. stock a buy before product launchesJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
No data: Challenges Affecting KALA Stock Movements - StocksToTrade
An analyst sees good growth prospects for Kala Bio Inc (KALA) - Setenews
KALA BIO's $6M Leadership Turnaround Boosts Shares - Mena FN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kala Bio secures $6 million investment as CEO changes amid trial failure By Investing.com - Investing.com Australia
KALA Stock Soars: Buying Opportunity? - StocksToTrade
KALA BIO, Inc. (KALA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November - Benzinga
Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
Kala Bio stock soars after $6M investment from David Lazar By Investing.com - Investing.com Nigeria
KALA’s Unexpected Surge: Unpacking the Recent Spike - timothysykes.com
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
0.18%
0.62%
大文字化:
|
ボリューム (24 時間):